Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
QuidelOrtho
QDEL
QuidelOrtho
Debt And Costs Will Squeeze Margins As Markets Rebound
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
07 Aug 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$26.00
7.3% overvalued
intrinsic discount
16 Aug
US$27.90
Loading
1Y
-37.5%
7D
8.1%
Author's Valuation
US$26.0
7.3% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$26.0
7.3% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-2b
3b
2014
2017
2020
2023
2025
2026
2028
Revenue US$2.9b
Earnings US$365.8m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
2.75%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
10.81%
Calculation
US$365.83m
Earnings '28
x
6.72x
PE Ratio '28
=
US$2.46b
Market Cap '28
US$2.46b
Market Cap '28
/
69.87m
No. shares '28
=
US$35.19
Share Price '28
US$35.19
Share Price '28
Discounted to 2025 @ 11.08% p.a.
=
US$25.68
Fair Value '25
